HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK
January 29, 2025 08:15 ET
|
Avricore Health Inc.
HealthTab integrates with UK’s leading patient personal health record, uploading results to patients' NHS records for seamless care.
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
November 29, 2024 07:30 ET
|
Avricore Health Inc.
Avricore Health Inc. (AVCR) releases its third-quarter results.
Avricore Health Refocuses Strategy to Unlock Growth Potential
November 14, 2024 18:01 ET
|
Avricore Health Inc.
Avricore Health (AVCR) makes a strategic shift to focus on UK market where it expects to take advantage of better market conditions.
Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch
November 06, 2024 15:14 ET
|
Avricore Health Inc.
Avricore earned 8th spot in Deloitte Canada’s 2024 Technology Fast 50™ Companies-to-Watch list, reflecting its significant growth.
Avricore Grants Options
August 30, 2024 21:29 ET
|
Avricore Health Inc.
Avricore Health issues stock options in accordance with plan.
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability
August 29, 2024 06:05 ET
|
Avricore Health Inc.
Avricore Health Inc. reports mid-year results demonstrating strong growth, second consecutive quarter of profitability.
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
June 03, 2024 08:00 ET
|
Avricore Health Inc.
Q1 2024 Results
Avricore Health Corporate Update and Audited Results for 2023
April 30, 2024 06:00 ET
|
Avricore Health Inc.
2023 audited financials show a near doubling of revenues and a strong growth trajectory.
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
April 04, 2024 07:30 ET
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Avricore Health Corporate Update – Company Demonstrates Strong Growth
November 30, 2023 12:58 ET
|
Avricore Health Inc.
Avricore Health provides a corporate update and results for the first 9 months of 2023.